These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 37090699)

  • 1. Syphilis vaccine: challenges, controversies and opportunities.
    Ávila-Nieto C; Pedreño-López N; Mitjà O; Clotet B; Blanco J; Carrillo J
    Front Immunol; 2023; 14():1126170. PubMed ID: 37090699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-pathogenic Borrelia burgdorferi expressing Treponema pallidum TprK and Tp0435 antigens as a novel approach to evaluate syphilis vaccine candidates.
    Parveen N; Fernandez MC; Haynes AM; Zhang RL; Godornes BC; Centurion-Lara A; Giacani L
    Vaccine; 2019 Mar; 37(13):1807-1818. PubMed ID: 30797635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Notes on syphilis vaccine development.
    Kojima N; Konda KA; Klausner JD
    Front Immunol; 2022; 13():952284. PubMed ID: 35967432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of syphilis immunology and Treponema pallidum subsp. pallidum biology to improve clinical management and design a broadly protective vaccine: study protocol.
    Osias E; Hung P; Giacani L; Stafylis C; Konda KA; Vargas SK; Reyes-Díaz EM; Comulada WS; Haake DA; Haynes AM; Caceres CF; Klausner JD
    BMC Infect Dis; 2020 Jun; 20(1):444. PubMed ID: 32576149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status of syphilis vaccine development: need, challenges, prospects.
    Cameron CE; Lukehart SA
    Vaccine; 2014 Mar; 32(14):1602-9. PubMed ID: 24135571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional and immunological analysis of the putative outer membrane protein and vaccine candidate TprL of Treponema pallidum.
    Haynes AM; Fernandez M; Romeis E; Mitjà O; Konda KA; Vargas SK; Eguiluz M; Caceres CF; Klausner JD; Giacani L
    PLoS Negl Trop Dis; 2021 Jan; 15(1):e0008812. PubMed ID: 33497377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress towards an effective syphilis vaccine: the past, present and future.
    Cullen PA; Cameron CE
    Expert Rev Vaccines; 2006 Feb; 5(1):67-80. PubMed ID: 16451109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two Potential Syphilis Vaccine Candidates Inhibit Dissemination of
    Xu M; Xie Y; Zheng K; Luo H; Tan M; Zhao F; Zeng T; Wu Y
    Front Immunol; 2021; 12():759474. PubMed ID: 34899710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the immune responses to Treponema pallidum Gpd DNA vaccine adjuvanted with IL-2 and chitosan nanoparticles before and after Treponema pallidum challenge in rabbits.
    Zhao F; Zhang X; Liu S; Zeng T; Yu J; Gu W; Zhang Y; Chen X; Wu Y
    Sci China Life Sci; 2013 Feb; 56(2):174-80. PubMed ID: 23334700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Attempts at developing a syphilis vaccine (author's transl)].
    Metzger M
    Dermatol Monatsschr; 1979 Apr; 165(4):257-63. PubMed ID: 378724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Modeling of the Treponema pallidum Outer Membrane Protein Repertoire: a Road Map for Deconvolution of Syphilis Pathogenesis and Development of a Syphilis Vaccine.
    Hawley KL; Montezuma-Rusca JM; Delgado KN; Singh N; Uversky VN; Caimano MJ; Radolf JD; Luthra A
    J Bacteriol; 2021 Jul; 203(15):e0008221. PubMed ID: 33972353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Protective Ability of the Treponema pallidum subsp.
    Haynes AM; Godornes C; Ke W; Giacani L
    Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31182617
    [No Abstract]   [Full Text] [Related]  

  • 13. An In Silico Identification of Common Putative Vaccine Candidates against Treponema pallidum: A Reverse Vaccinology and Subtractive Genomics Based Approach.
    Kumar Jaiswal A; Tiwari S; Jamal SB; Barh D; Azevedo V; Soares SC
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cell-surface exposure and vaccinogenic potentials of Treponema pallidum candidate outer membrane proteins.
    Tomson FL; Conley PG; Norgard MV; Hagman KE
    Microbes Infect; 2007 Sep; 9(11):1267-75. PubMed ID: 17890130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancements in the development of nucleic acid vaccines for syphilis prevention and control.
    Li S; Li W; Jin Y; Wu B; Wu Y
    Hum Vaccin Immunother; 2023 Aug; 19(2):2234790. PubMed ID: 37538024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of the immune escape mechanism of Treponema pallidum.
    Tang Y; Zhou Y; He B; Cao T; Zhou X; Ning L; Chen E; Li Y; Xie X; Peng B; Hu Y; Liu S
    Infection; 2023 Apr; 51(2):305-321. PubMed ID: 36260281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syphilis Vaccine Development: Requirements, Challenges, and Opportunities.
    Cameron CE
    Sex Transm Dis; 2018 Sep; 45(9S Suppl 1):S17-S19. PubMed ID: 29528992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A defined syphilis vaccine candidate inhibits dissemination of Treponema pallidum subspecies pallidum.
    Lithgow KV; Hof R; Wetherell C; Phillips D; Houston S; Cameron CE
    Nat Commun; 2017 Feb; 8():14273. PubMed ID: 28145405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Loops of the Treponema pallidum FadL Orthologs TP0856 and TP0858 Elicit IgG Antibodies and IgG
    Delgado KN; Montezuma-Rusca JM; Orbe IC; Caimano MJ; La Vake CJ; Luthra A; Hennelly CM; Nindo FN; Meyer JW; Jones LD; Parr JB; Salazar JC; Moody MA; Radolf JD; Hawley KL
    mBio; 2022 Aug; 13(4):e0163922. PubMed ID: 35862766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Cell Epitope Mapping of TprC and TprD Variants of
    Molini B; Fernandez MC; Godornes C; Vorobieva A; Lukehart SA; Giacani L
    Front Immunol; 2022; 13():862491. PubMed ID: 35422800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.